Status: current, Primitive. Date: 31-Jul 2009. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2816491019 | Fesoterodine fumarate | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 2816492014 | Fesoterodine fumarate (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fesoterodine fumarate | Is a | Diarylmethane | true | Inferred relationship | Some | ||
| Fesoterodine fumarate | Is a | Fesoterodine | false | Inferred relationship | Some | ||
| Fesoterodine fumarate | Has disposition | Muscarinic receptor antagonist | true | Inferred relationship | Some | ||
| Fesoterodine fumarate | Is a | Muscarinic receptor antagonist | true | Inferred relationship | Some | ||
| Fesoterodine fumarate | Is modification of | Fesoterodine | true | Inferred relationship | Some | ||
| Fesoterodine fumarate | Is a | Smooth muscle relaxant | true | Inferred relationship | Some | ||
| Fesoterodine fumarate | Is a | Acetylcholine receptor antagonist | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fesoterodine fumarate 8 mg prolonged-release oral tablet | Has precise active ingredient | True | Fesoterodine fumarate | Inferred relationship | Some | 1 |
| Fesoterodine fumarate 8 mg prolonged-release oral tablet | Has BoSS | True | Fesoterodine fumarate | Inferred relationship | Some | 1 |
| Fesoterodine fumarate 4 mg prolonged-release oral tablet | Has precise active ingredient | True | Fesoterodine fumarate | Inferred relationship | Some | 1 |
| Fesoterodine fumarate 4 mg prolonged-release oral tablet | Has BoSS | True | Fesoterodine fumarate | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR